High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a devastating blood cancer with high heterogeneity and ill-fated outcome. Despite numerous advances in AML treatment, the prognosis remains poor for a significant proportion of patients. Consequently, it is necessary to accurately and comprehensively identify biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bichen, Wang, Wenjun, Li, Qiaoli, Guo, Tengxiao, Yang, Shuang, Shi, Jun, Yuan, Weiping, Chu, Yajing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355208/
https://www.ncbi.nlm.nih.gov/pubmed/37476188
http://dx.doi.org/10.7150/jca.84215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355208/
https://www.ncbi.nlm.nih.gov/pubmed/37476188
http://dx.doi.org/10.7150/jca.84215

Ejemplares similares